New CFO appointed at Intercytex
This article was originally published in Scrip
Intercytex Group (UK), a developer of regenerative medicine products to restore skin and hair, has appointed Max Herrmann chief financial officer, effective September 19th. Mr Herrmann joins from Fusion IP, a university IP commercialisation company, where he has held an independent consulting role for the past 12 months.
You may also be interested in...
The new Eudamed database may be delayed for two years, but the European Commission wants to allow early access to Single Registration Numbers before Eudamed goes live in 2022 to aid voluntary registration in the interim.
The US Senate on a 72-18 vote approved radiation oncologist Stephen Hahn as Commissioner of the FDA on 12 December. Voting “no” were a block of liberal Democrats, including the ranking member of a key Senate health committee. Industry advocates and most senators said Hahn is an excellent choice to lead the FDA, but some fear he will not move quickly enough to ban candy flavors in vaping products favored by teens.